Chieh-Ming (Ben) Hsu

FDA Accepts Outlook Therapeutics' BLA For Ophthalmic Bevacizumab

Lupin Announces Approval Of ENBREL Biosimilar In Canada

Supreme Court Cert Petitions On Skinny Label Inducement And Written Description Issues

U.S. Senators Request PTO Action On Patent Thickets

Formycon AG Acquires Biosimilar Assets Ustekinumab And Ranibuzumab

Biosimilar Deal Watch: Formycon/ATHOS, Fresenius/mAbxience/Ivenix, And Intas/Axantia

FDA Accepts Alvotech's BLA Supporting Interchangeability For ATV02, A High Concentration, Citrate-Free Biosimilar Candidate For Humira®